Edition:
United Kingdom

Tenax Therapeutics Inc (TENX.OQ)

TENX.OQ on NASDAQ Stock Exchange Capital Market

5.16USD
15 Aug 2018
Change (% chg)

$-0.60 (-10.42%)
Prev Close
$5.76
Open
$5.83
Day's High
$5.88
Day's Low
$5.16
Volume
5,178
Avg. Vol
4,968
52-wk High
$12.59
52-wk Low
$4.42

Chart for

About

Tenax Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on identifying, developing and commercializing products for the critical care market. The Company's main product is levosimendan. Levosimendan is a calcium sensitizer developed for intravenous use in hospitalized patients with acutely... (more)

Overall

Beta: 1.92
Market Cap(Mil.): $14.39
Shares Outstanding(Mil.): 28.24
Dividend: --
Yield (%): --

Financials

  TENX.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -1.43 -- --
ROI: -114.61 1.78 14.61
ROE: -129.29 3.28 16.33

Competitors

  Price Chg
Novartis AG (NOVN.S) CHF80.86 -0.66
Merck & Co., Inc. (MRK.N) $67.37 +0.91
Roche Holding Ltd. (ROG.S) CHF237.25 -2.25
Roche Holding Ltd. (RO.S) CHF240.60 -2.40
Abbott Laboratories (ABT.N) $63.47 -0.16
Bayer AG (BAYGn.DE) €80.79 -2.97
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €72.16 -0.69
Eli Lilly And Co (LLY.N) $103.33 +0.89
Bristol-Myers Squibb Co (BMY.N) $60.26 +0.30

Earnings vs. Estimates